Jerome Lorenzini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jerome Lorenzini has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Camille Mimoun
Service de gynécologie obstétrique, hôpital Lariboisière, Paris-Cité université, AP-HP, Paris, France
2 shared publications - Cyril Touboul
Department of Gynecology-Obstetrics, Expert center in Gynecology-Oncology, Tenon Hospital, Assistance Publique des Hôpitaux de Paris (APHP), Sorbonne University, Paris, France
2 shared publications - Cyrille Huchon
APHP. Service de gynécologie & obstétrique, GH Saint-Louis Lariboisière-Fernand Widal, Hôpital Lariboisière, Université de Paris, 2, rue Ambroise Paré, 75010 Paris, France
2 shared publications - Lobna Ouldamer
Department of Gynaecology, Centre Hospitalier Universitaire de Tours, Tours, France; INSERM U1069 Université François-Rabelais, Tours, France
2 shared publications - Vincent Lavoué
Department of Gynaecology, CHU de Rennes, France; INSERM, 1242, COSS, Rennes, Université de Rennes 1, France
2 shared publications - Yohann Dabi
Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Faculté de Médecine Sorbonne Université, Institut Universitaire de Cancérologie (IUC), France
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 37 (2)
Impact of lymph node staging on survival in presumed early-stage ovarian cancer: a multicentric retrospective study
Ouasti S, et al. J Gynecol Oncol. 2025 Nov;37:e31. https://doi.org/10.3802/jgo.2026.37.e31
- 1 January 2026
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 37 (2)
Open AccessImpact of lymph node staging on survival in presumed early-stage ovarian cancer: a multicentric retrospective study
Ouasti S, et al. J Gynecol Oncol. 2025 Nov;37:e31. https://doi.org/10.3802/jgo.2026.37.e31
- Open Access
- 17 October 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (20) , 6120
Presentation and Prognosis of Primary Expansile and Infiltrative Mucinous Carcinomas of the Ovary
Objective: The aim of the present study was to evaluate evolution and prognosis of mucinous ovarian carcinomas (mOC), with respect to the two invasive patterns: expansile and infiltrative invasion. Methods: This was a descriptive, retrospective, multicenter study conducted in 13 French centres from 1 January 2001 to 31 December 2019. All patients operated on for epithelial ovarian neoplasia of the mucinous type (infiltrative/expansile) were included, whether the surgery was performed immediately or after neoadjuvant chemotherapy. Results: A total of 94 women with mucinous carcinomas were included in the present study. Mucinous tumours were divided into 35 expansile (37%) and 59 infiltrative (63%) mOC. There was a statistically significant difference in early and late stages at initial diagnosis between expansile and infiltrative mOC. None of the expansile mOC showed metastatic lymph nodes, whereas almost a quarter of the infiltrative mOC were metastatic to the pelvic/para-aortic region. There was a clear difference in RFS, in favour of expansile mOC, with 90% survival at 5 years, compared with 60% for infiltrative mOC. Conclusions: Although infiltrative and expansile mOC belong to the same histological family, they present many distinctions in clinical presentation, histological invasion, and disease course.
- 17 October 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (20) , 6120
Open AccessPresentation and Prognosis of Primary Expansile and Infiltrative Mucinous Carcinomas of the Ovary
Objective: The aim of the present study was to evaluate evolution and prognosis of mucinous ovarian carcinomas (mOC), with respect to the two invasive patterns: expansile and infiltrative invasion. Methods: This was a descriptive, retrospective, multicenter study conducted in 13 French centres from 1 January 2001 to 31 December 2019. All patients operated on for epithelial ovarian neoplasia of the mucinous type (infiltrative/expansile) were included, whether the surgery was performed immediately or after neoadjuvant chemotherapy. Results: A total of 94 women with mucinous carcinomas were included in the present study. Mucinous tumours were divided into 35 expansile (37%) and 59 infiltrative (63%) mOC. There was a statistically significant difference in early and late stages at initial diagnosis between expansile and infiltrative mOC. None of the expansile mOC showed metastatic lymph nodes, whereas almost a quarter of the infiltrative mOC were metastatic to the pelvic/para-aortic region. There was a clear difference in RFS, in favour of expansile mOC, with 90% survival at 5 years, compared with 60% for infiltrative mOC. Conclusions: Although infiltrative and expansile mOC belong to the same histological family, they present many distinctions in clinical presentation, histological invasion, and disease course.